Developmental Genes and Regulatory Proteins, Domains of Cognitive Impairment in Schizophrenia Spectrum Psychosis and Implications for Antipsychotic Drug Discovery: The Example of Dysbindin-1 Isoforms and Beyond.
Issue Date
2020-01-29Keywords
antipsychotic drug developmentcognitive deficits
developmental gene
dysbindin-1
SCHIZOPHRENIA
Metadata
Show full item recordJournal
Frontiers in pharmacologyDOI
10.3389/fphar.2019.01638PubMed ID
32063853Item Type
ArticleOther
Language
enISSN
1663-9812ae974a485f413a2113503eed53cd6c53
10.3389/fphar.2019.01638
Scopus Count
Collections
Related articles
- Dysbindin-1 in dorsolateral prefrontal cortex of schizophrenia cases is reduced in an isoform-specific manner unrelated to dysbindin-1 mRNA expression.
- Authors: Tang J, LeGros RP, Louneva N, Yeh L, Cohen JW, Hahn CG, Blake DJ, Arnold SE, Talbot K
- Issue date: 2009 Oct 15
- Synaptic dysbindin-1 reductions in schizophrenia occur in an isoform-specific manner indicating their subsynaptic location.
- Authors: Talbot K, Louneva N, Cohen JW, Kazi H, Blake DJ, Arnold SE
- Issue date: 2011 Mar 1
- Dysbindin gene variability is associated with cognitive abnormalities in first-episode non-affective psychosis.
- Authors: Varela-Gomez N, Mata I, Perez-Iglesias R, Rodriguez-Sanchez JM, Ayesa R, Fatjo-Vilas M, Crespo-Facorro B
- Issue date: 2015
- Single point mutation on the gene encoding dysbindin results in recognition deficits.
- Authors: Chang EH, Fernando K, Yeung LWE, Barbari K, Chandon TS, Malhotra AK
- Issue date: 2018 Jun
- Increased dysbindin-1B isoform expression in schizophrenia and its propensity in aggresome formation.
- Authors: Xu Y, Sun Y, Ye H, Zhu L, Liu J, Wu X, Wang L, He T, Shen Y, Wu JY, Xu Q
- Issue date: 2015